4186 Stock Overview
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Taiwan Advance Bio-Pharmaceutical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$15.60 |
| 52 Week High | NT$21.80 |
| 52 Week Low | NT$14.00 |
| Beta | 0.85 |
| 1 Month Change | 4.35% |
| 3 Month Change | 2.30% |
| 1 Year Change | -20.61% |
| 3 Year Change | -30.51% |
| 5 Year Change | -34.95% |
| Change since IPO | -79.06% |
Recent News & Updates
Shareholder Returns
| 4186 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 4.7% | 1.6% | 2.8% |
| 1Y | -20.6% | -24.5% | 27.4% |
Return vs Industry: 4186 exceeded the TW Biotechs industry which returned -22.6% over the past year.
Return vs Market: 4186 underperformed the TW Market which returned 27.2% over the past year.
Price Volatility
| 4186 volatility | |
|---|---|
| 4186 Average Weekly Movement | 4.2% |
| Biotechs Industry Average Movement | 4.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4186 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4186's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 154 | n/a | www.biotest.com.tw |
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse.
Taiwan Advance Bio-Pharmaceutical Inc. Fundamentals Summary
| 4186 fundamental statistics | |
|---|---|
| Market cap | NT$1.40b |
| Earnings (TTM) | -NT$10.68m |
| Revenue (TTM) | NT$315.98m |
4.4x
P/S Ratio-131.4x
P/E RatioIs 4186 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4186 income statement (TTM) | |
|---|---|
| Revenue | NT$315.98m |
| Cost of Revenue | NT$117.53m |
| Gross Profit | NT$198.46m |
| Other Expenses | NT$209.14m |
| Earnings | -NT$10.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 62.81% |
| Net Profit Margin | -3.38% |
| Debt/Equity Ratio | 112.5% |
How did 4186 perform over the long term?
See historical performance and comparison